CR6858A - COMPOSITIONS OF ELETRIPTAN IN THE FORM OF PARTICLES SHOWING THE SIGMOID COURSE OF CONTROLLED LIBERATION - Google Patents
COMPOSITIONS OF ELETRIPTAN IN THE FORM OF PARTICLES SHOWING THE SIGMOID COURSE OF CONTROLLED LIBERATIONInfo
- Publication number
- CR6858A CR6858A CR6858A CR6858A CR6858A CR 6858 A CR6858 A CR 6858A CR 6858 A CR6858 A CR 6858A CR 6858 A CR6858 A CR 6858A CR 6858 A CR6858 A CR 6858A
- Authority
- CR
- Costa Rica
- Prior art keywords
- eletriptan
- compositions
- sigmoid
- particles showing
- course
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000002245 particle Substances 0.000 title abstract 2
- OTLDLQZJRFYOJR-LJQANCHMSA-N eletriptan Chemical group CN1CCC[C@@H]1CC1=CN=C2[C]1C=C(CCS(=O)(=O)C=1C=CC=CC=1)C=C2 OTLDLQZJRFYOJR-LJQANCHMSA-N 0.000 title 1
- 229960002472 eletriptan Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 229920006243 acrylic copolymer Polymers 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000013267 controlled drug release Methods 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- USFMMZYROHDWPJ-UHFFFAOYSA-N trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium Chemical group CC(=C)C(=O)OCC[N+](C)(C)C USFMMZYROHDWPJ-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invencion proporciona una composicion farmaceutica en forma de particulas, adecuada para la administracion por via oral, que incluye un nucleo que contiene eleptritan o una sal farmaceuticamente aceptable del mismo, estando revestido el nucleo con un revestimiento insoluble en agua, y permeable, que incluye uno o mas copolimeros acrilicos que contienen grupos de metacrilato de trimetilamonioetilo y siendo dicha composicion capaz de conseguir un curso sigmoideo de liberacion controlada del farmaco. Esra composicion farmaceutica es particularmente util en la prevencion de la recurrencia de la migranaThis invention provides a pharmaceutical composition in the form of particles, suitable for oral administration, which includes a nucleus containing eleptritan or a pharmaceutically acceptable salt thereof, the core being coated with a water insoluble coating, and permeable, which includes one or more acrylic copolymers containing trimethylammonioethyl methacrylate groups and said composition being capable of achieving a controlled drug release sigmoid course. This pharmaceutical composition is particularly useful in preventing migraine recurrence.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR6858A CR6858A (en) | 2002-12-13 | 2002-12-13 | COMPOSITIONS OF ELETRIPTAN IN THE FORM OF PARTICLES SHOWING THE SIGMOID COURSE OF CONTROLLED LIBERATION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR6858A CR6858A (en) | 2002-12-13 | 2002-12-13 | COMPOSITIONS OF ELETRIPTAN IN THE FORM OF PARTICLES SHOWING THE SIGMOID COURSE OF CONTROLLED LIBERATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR6858A true CR6858A (en) | 2004-02-02 |
Family
ID=44839085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR6858A CR6858A (en) | 2002-12-13 | 2002-12-13 | COMPOSITIONS OF ELETRIPTAN IN THE FORM OF PARTICLES SHOWING THE SIGMOID COURSE OF CONTROLLED LIBERATION |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR6858A (en) |
-
2002
- 2002-12-13 CR CR6858A patent/CR6858A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR030099A1 (en) | COMPOSITION OF ELETRIPTAN IN THE FORM OF PARTICLES | |
| BR0312347A (en) | Oral Pharmaceutical Composition, Uses of Coating Thickness of a Dissolving Ph Dependent Coating Material, Coating Material, and Polymethacrylate Material | |
| PE20191048A1 (en) | PHARMACEUTICAL DOSAGE FORMS | |
| TW200635897A (en) | Piperidine derivatives and their use as anti-inflammatory agents | |
| CY1106072T1 (en) | ORAL EXTENDED RELEASE DOSAGE FORM | |
| ES2185816T3 (en) | FORMS OF PHARMACEUTICAL DOSAGE FOR THE ORAL ROUTE, WHICH INCLUDE AN INHIBITING AGENT OF THE PUMP OF PROTONS AND A PROCEDURAL AGENT. | |
| AR110010A2 (en) | PHARMACEUTICAL COMPOSITION FORMULATED IN A SINGLE DOSE FORM OF 2- [6- (3-AMINO-PIPERIDIN-1-IL) -3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-ILLAMBLE ] -4-FLUORO-BENZONITRILO | |
| ATE266390T1 (en) | PUSH RELEASE DRUG DELIVERY SYSTEMS | |
| AR065809A1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING AN SGLT2 INHIBITOR | |
| MX350380B (en) | Zero-order modified release solid dosage forms. | |
| BR0211317A (en) | System for controlled drug release through gastric retention | |
| DE60032749D1 (en) | STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN NON-TEROID INFUSE-INFLAMMATIVE AGGREGATE AND PROSTAGLANDIN | |
| MA29115B1 (en) | SOLID PHARMACEUTICAL PRODUCTS, ORAL ADMINISTERED AND CONTAINING RIVAROXABAN, MODIFIED RELEASE | |
| AR076540A1 (en) | COMPOSITIONS OF ORAL DISINTEGRATION TABLETS THAT INCLUDE COMBINATIONS OF NON-OPIOID AND OPIOID ANALGESICS, DOSAGE FORM. PREPARATION METHOD. METHOD TO TREAT PAIN | |
| BRPI0414082A (en) | Sustained-release dosage forms of ziprasidone | |
| EP1781257A4 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING MICROPARTICLES OR NANOPARTICLES OF AN ADMINISTRATION AGENT | |
| GT200600474A (en) | SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALINE | |
| EP2085076A4 (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF COATED MICROSPHERES FOR THE MODIFIED RELEASE OF A MYORELAXANT AND A NSAID | |
| GT200600500A (en) | ORODISPERSABLE PHARMACEUTICAL COMPOSITION FOR THE OROMUCOSAL OR SUBLINGUAL ADMINISTRATION OF AGOMELATIN | |
| DE602004023093D1 (en) | N WITH A DISPENSER IN MICRONIZED FORM | |
| BR0013719A (en) | Controlled-release oral dosage, suitable for oral administration | |
| Briner et al. | New approaches to rapid onset antidepressants | |
| WO2004062552A3 (en) | Pharmaceutical composition containing a nsaid and a benzimidazole derivative | |
| ATE367153T1 (en) | MULTIPARTICULAR MEDICINAL COMPOSITIONS WITH CONTROLLED ACTIVE RELEASE CONTAINING SELECTIVE INHIBITORS OF SEROTONIN REUPtake | |
| UY28457A1 (en) | NEW COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |